These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9718631)

  • 1. Higher cerebrospinal fluid angiotensin-converting enzyme levels in neuroleptic-treated than in drug-free patients with schizophrenia.
    Wahlbeck K; Ahokas A; Miettinen K; Nikkilä H; Rimón R
    Schizophr Bull; 1998; 24(3):391-7. PubMed ID: 9718631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated angiotensin-converting enzyme (kininase II) in the cerebrospinal fluid of neuroleptic-treated schizophrenic patients.
    Wahlbeck K; Rimón R; Fyhrquist F
    Schizophr Res; 1993 Mar; 9(1):77-82. PubMed ID: 8096392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal study of cerebrospinal fluid angiotensin-converting enzyme in neuroleptic-treated schizophrenia.
    Wahlbeck K; Ahokas A; Nikkilä H; Miettinen K; Rimón R
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 May; 21(4):591-9. PubMed ID: 9194142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid angiotensin-converting enzyme (ACE) correlates with length of illness in schizophrenia.
    Wahlbeck K; Ahokas A; Nikkilä H; Miettinen K; Rimón R
    Schizophr Res; 2000 Jan; 41(2):335-40. PubMed ID: 10708342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current antipsychotic dose correlates to mononuclear cell counts in the cerebrospinal fluid of psychotic patients.
    Wahlbeck K; Nikkilä H; Rimón R; Ahokas A
    Psychiatry Res; 2000 Feb; 93(1):13-9. PubMed ID: 10699224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication.
    Glovinsky D; Kalogeras KT; Kirch DG; Suddath R; Wyatt RJ
    Schizophr Res; 1994 Feb; 11(3):273-6. PubMed ID: 7910756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low angiotensin-converting enzyme activity (kininase II) in cerebrospinal fluid of schizophrenics.
    Beckmann H; Saavedra JM; Gattaz WF
    Biol Psychiatry; 1984 May; 19(5):679-84. PubMed ID: 6145452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma vasopressin and normal cerebrospinal fluid angiotensin-converting enzyme in chronic pain disorder.
    Wahlbeck K; Sundblom M; Kalso E; Tigerstedt I; Rimón R
    Biol Psychiatry; 1996 Nov; 40(10):994-9. PubMed ID: 8915558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of angiotensin-converting enzyme gene polymorphism with schizophrenia and polydipsia.
    Ouyang WC; Wang YC; Hong CJ; Cheng CY; Tsai SJ
    Neuropsychobiology; 2001; 44(1):31-5. PubMed ID: 11408790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid inositol monophosphatase: elevated activity in depression and neuroleptic-treated schizophrenia.
    Atack JR; Levine J; Belmaker RH
    Biol Psychiatry; 1998 Sep; 44(6):433-7. PubMed ID: 9777174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay and biochemical characterization of angiotensin-I-converting enzyme in cerebrospinal fluid.
    Schweisfurth H; Schiöberg-Schiegnitz S
    Enzyme; 1984; 32(1):12-9. PubMed ID: 6090116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment.
    Ebstein RP; Biederman J; Rimon R; Zohar J; Belmaker RH
    Psychopharmacology (Berl); 1976 Dec; 51(1):71-4. PubMed ID: 13448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis.
    Kawajiri M; Mogi M; Higaki N; Matsuoka T; Ohyagi Y; Tsukuda K; Kohara K; Horiuchi M; Miki T; Kira JI
    Mult Scler; 2009 Feb; 15(2):262-5. PubMed ID: 19136547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme in cerebrospinal fluid: a new assay.
    Oksanen V; Fyhrquist F; Somer H; Grönhagen-Riska C
    Neurology; 1985 Aug; 35(8):1220-3. PubMed ID: 2991815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients.
    Licinio J; Seibyl JP; Altemus M; Charney DS; Krystal JH
    Am J Psychiatry; 1993 Sep; 150(9):1408-10. PubMed ID: 8102512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid angiotensin converting enzyme levels in the diagnosis of neurosarcoidosis.
    Jones DB; Mitchell D; Horn DB; Edwards CR
    Scott Med J; 1991 Oct; 36(5):144-5. PubMed ID: 1664971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF dopamine beta-hydroxylase in schizophrenia.
    Sternberg DE; van Kammen DP; Lerner P; Ballenger JC; Marder SR; Post RM; Bunney WE
    Arch Gen Psychiatry; 1983 Jul; 40(7):743-7. PubMed ID: 6134515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects.
    Rao ML; Gross G; Strebel B; Bräunig P; Huber G; Klosterkötter J
    Psychiatry Res; 1990 Dec; 34(3):243-57. PubMed ID: 1981623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid and serum levels of neuron-specific enolase in patients with schizophrenia.
    Egan MF; el-Mallakh RS; Suddath RL; Lohr JB; Bracha HS; Wyatt RJ
    Psychiatry Res; 1992 Aug; 43(2):187-95. PubMed ID: 1357702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF levels of receptor-active endorphins in schizophrenic patients: correlations with symptomatology and monoamine metabolites.
    Lindström LH; Besev G; Gunne LM; Terenius L
    Psychiatry Res; 1986 Oct; 19(2):93-100. PubMed ID: 2431427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.